Tianda Pharmaceuticals Limited (HKG:0455)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.0990
-0.0020 (-1.98%)
At close: Mar 10, 2026
Market Cap212.85M -46.5%
Revenue (ttm)310.50M -19.3%
Net Income-67.37M
EPS-0.03
Shares Out2.15B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume112,000
Average Volume55,600
Open0.1000
Previous Close0.1010
Day's Range0.0970 - 0.1000
52-Week Range0.0930 - 0.2150
Beta-0.28
RSI35.97
Earnings DateMar 27, 2026

About Tianda Pharmaceuticals

Tianda Pharmaceuticals Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. It operates through the Chinese Medicine, Pharmaceuticals and Medical Technologies, and Medical and Healthcare Services segments. The company offers Chinese herbal medicine, Chinese medicine decoction pieces, Chinese medicine products, and Chinese medicine clinical services. It also produces pharmaceutical products foc... [Read more]

Sector Healthcare
Founded 1992
Employees 624
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0455
Full Company Profile

Financial Performance

In 2024, Tianda Pharmaceuticals's revenue was 329.94 million, a decrease of -37.99% compared to the previous year's 532.09 million. Losses were -61.37 million, 154.1% more than in 2023.

Financial Statements